<DOC>
	<DOCNO>NCT01614106</DOCNO>
	<brief_summary>This study evaluate efficacy integrate `` Retention Clinic '' achieve virologic suppression among HIV-infected cocaine ( include crack ) user use two-group randomize , prospective trial . Eligible participant randomize one follow two group : 1 ) `` Retention Clinic '' 2 ) Treatment Usual . The intervention ( `` Retention Clinic '' ) group receive 11 Patient Navigator session 6 month period 9 session substance abuse treatment 3 month period . Follow-up assessment conduct 6 12 month post-randomization . Medical record review document use HIV care , drug treatment mental health service study period . A total 360 HIV-infected individual report cocaine ( include crack ) use randomize across site ( Miami , FL , Atlanta , GA ) . Primary hypothesis participant randomize `` Retention Clinic '' undetectable viral load participant randomize treatment usual group .</brief_summary>
	<brief_title>Project RETAIN : Providing Integrated Care HIV-Infected Crack Cocaine Users</brief_title>
	<detailed_description>This study evaluate efficacy integrate `` Retention Clinic '' achieve virologic suppression among HIV-infected cocaine ( include crack ) user use two-group randomize , prospective trial . Participants randomize one two group : 1 ) `` Retention Clinic '' group 2 ) Treatment Usual . The intervention content group briefly describe : Retention Clinic ( RC ) Group : This group receive comprehensive integrate service Retention Clinic . Services include HIV primary care , substance abuse treatment mental health service , need . Participants group also receive hands-on assistance navigate clinic accessing service patient navigator . Treatment Usual ( TAU ) Group : This group receive protocol direct intervention . They get standard retention service local clinic . All participant provide informed consent complete baseline audio computer-assisted self-interview ACASI focus drug use , mental health , demographic socio-economic factor , HIV care , drug treatment history well blood draws viral load CD4 count . Follow-up assessment consist ACASI blood draw group collect 6 12 month post-randomization . Medical record review document use HIV care , drug treatment mental health service study period .</detailed_description>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>Participating individual must : 1. least 18 year old 2. HIVseropositive ( confirm via medical record/laboratory result via rapid HIV test conjunction confirmatory test viral load ) 3. meet one follow : ) ( * ) AIDSdefining illness OR b ) CD4 count &lt; 350 cells/uL AND viral load &gt; 1000 copies/mL medical record past 3 month OR c ) CD4 count &lt; 350 cells/uL AND viral load &gt; 200 copies/mL obtain via baseline blood draw OR ) clinical profile indicative persistently detectable HIV viral load ( &gt; 200 copies/mL ) attribute nonadherence HIV medication per PI evaluation individual and/or individual 's medical record 4. report ( OR evidence medical record ) cocaine ( include crack ) use past 3 month OR ( ** ) positive toxicology result cocaine via study toxicology screen 5. agree blood drawn CD4 viral load test 6. report living near either Miami , FL , Atlanta , GA , able return followup visit 7. provide locator information 8. able communicate English 9. provide write informed consent 10. sign HIPAA Authorization form/medical record release facilitate medical record abstraction 11. willing go study clinic ( * ) Site PI discretion use assess whether AIDSdefining illness good indicator eligibility . For example , patient meet CD4 viral load criterion AIDSdefining illness , Site PI ass AIDSdefining illness determine whether patient suitable candidate study . ( ** ) Per PI discretion , urine toxicology screen may administer part screen process participant 's selfreport and/or medical record data render him/her ineligible drug use criterion . Individuals exclude study participation : 1. meet one abovedescribed inclusion criterion 2. receive patient navigator service HIV care and/or substance abuse treatment 3. significant cognitive developmental impairment extent unable provide inform consent 4. terminate via site PI decision</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>HIV/AIDS</keyword>
	<keyword>Drug Users</keyword>
	<keyword>Crack-Cocaine Use</keyword>
	<keyword>HIV Primary Care</keyword>
</DOC>